TriMedika Ltd, a UK manufacturer of innovative medical devices, are excited to announce they have partnered with ABHI for their US Accelerator Program 2022. TriMedika representatives will attend trade missions and networking events in the US as part of this yearly program.
TriMedika is redefining healthcare by providing the most accurate clinical thermometers for hospitals worldwide.
Back in 2016 (long before COVID) TriMedika realized that contact thermometers were a huge source of infection, but at that time thermometer technology hadn’t moved on for a number of years. To improve vital patient care with technology that safeguards patients and carers, TriMedika designed a non-contact infrared thermometer. TRITEMP™ has been precision engineered to withstand use in a busy clinical setting.
TriMedika distributes TRITEMP™ to over 21 countries internationally. The product is listed on major buying platforms including NHS Supply Chain, the Health Service Executive in Ireland and equivalent frameworks in countries such as Germany, Switzerland and Austria.
TriMedika plan to scale the business fast through product diversification, including connected devices, and market diversification into the US this year with expressions of interest already secured from GPOs, IDNs and hospital systems.
We are excited to announce the key dates and locations for the first 3 trade missions, as part of the ABHI Accelerator Program.
Key dates and locations:
Texas – Dallas, Austin, Houston – 28th February – 4th March
California – Los Angeles & San Francisco – 16th – 20th May
Tennessee – Nashville & Memphis – 25th – 29th July
We are looking to speak with representatives from GPO’s, IDN’s and hospital systems who would like to trial innovative technology that improves infection control strategies, sustainability agendas, procurement budgets and overall patient outcomes.
If you would like to schedule a meeting ahead of the trade mission, email Jenny Cromie. US Key Account Manager jcromie@trimedika.com
